Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • Pharmaindustrie / Medikamente
  • Schmerzen / Migräne / Analgetika
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Belgien
  • Bosnien-Herzegowina
  • Bulgarien
  • Dänemark
  • Deutschland
  • Estland
  • Finnland
  • Frankreich
  • Griechenland
  • Irland
  • Italien
  • Kroatien
  • Lettland
  • Litauen
  • Mazedonien
  • Niederlande
  • Norwegen
  • Österreich
  • Poland
  • Portugal
  • Rumänien
  • Russian Federation
  • Schweden
  • Schweiz
  • Serbien
  • Slowakei
  • Slowenien
  • Spanien
  • Tschechien
  • Türkei
  • Ukraine
  • Ungarn
  • Vereinigtes Königreich
  • Weißrussland
  • Weißrussland
  • Asien / Pazifik
  • China
  • Hong Kong
  • Indien
  • Indonesien
  • Japan
  • Kasachstan
  • Malaysia
  • Neuseeland
  • Pakistan
  • Philippinen
  • Singapur
  • Südkorea
  • Taiwan
  • Thailand
  • Usbekistan
  • Vietnam
  • Mittlerer Osten / Afrika
  • Ägypten
  • Algerien
  • Iran
  • Israel
  • Kamerun
  • Kenia
  • Marokko
  • Nigeria
  • Saudi Arabien
  • South Africa
  • Tunesien
  • Vereinigte Arabische Emirate
  • Nordamerika / USA
  • Kanada
  • United States
  • Australien
  • Mittel- / Südamerika
  • Argentinien
  • Bolivien
  • Brasilien
  • Chile
  • Costa Rica
  • Kolumbien
  • Mexiko
  • Peru
  • Uruguay
  • Venezuela
  • Filter zurücksetzen
Herausgeber
  • Biopharm Reports
  • Canadean
  • Datamonitor
  • Euromonitor
  • GBI Research
  • Global Markets Direct
  • GlobalData
  • Life Science Analytics
  • Technavio
  • Filter zurücksetzen
Sprache
  • Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • Filter zurücksetzen
laedt

Marktanalyse - Cough, Cold and Allergy (Hay Fever) Remedies in Belgium

Euromonitor

Euromonitor

6 / 2012
42 Seiten
Typ: Marktanalyse
Sprache: Englisch
Regionen: Belgien
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

675,00 €*
PDF-Datei per E-Mail , versandkostenfrei


In 2011 cough, cold and allergy (hay fever) remedies’ volume sales suffered as a result of 'unfavourable” weather — after the cold autumn of 2010, the winter and autumn seasons in 2011 were very mild, and the number of outbreaks of infectious diseases was lower than is typical. Also, many years after the questioning of combination cough, cold and allergy remedies — as a result of which most were withdrawn — the category was again questioned by the Commission des Médicaments, particularly...

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN BELGIUM

Euromonitor International

June 2012



LIST OF CONTENTS AND TABLES



Headlines

Trends

Switches

Competitive Landscape

Prospects

Category Data

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011

Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011

Table 3 Sales of Decongestants by Category: Value 2006-2011

Table 4 Sales of Decongestants by Category: % Value Growth 2006-2011

Table 5 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011

Table 6 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011

Table 7 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011

Table 8 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011

Table 9 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016

Table 10 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Laboratoria Qualiphar NV SA in Consumer Health (belgium)

Strategic Direction

Key Facts

Summary 1 Qualiphar NV SA, Laboratoria: Key Facts

Summary 2 Qualiphar NV SA, Laboratoria: Operational Indicators

Company Background and Production

Competitive Positioning

Summary 3 Qualiphar NV SA, Laboratoria: Competitive Position 2011

Tilman NV SA in Consumer Health (belgium)

Strategic Direction

Key Facts

Summary 4 Tilman NV SA: Key Facts

Summary 5 Tilman NV SA: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 6 Tilman NV SA: Competitive Position 2011

Executive Summary

Slight But Fragile Recovery in 2011

Negative Environment for Consumer Health Affects Sales

Disparate Results in A Still Fragmented Competitive Environment

Distribution Remains Under the Control of Pharmacies Despite Some Changes

Bleak Prospects Overall

Key Trends and Developments

Fragile Economic Recovery To Result in A Temporary Improvement

Authorities and Medical Experts Blow Hot and Cold

More Health & Wellness, Certainly, But Also More Realism

Remedies for Increasingly Stressful Lifestyles

Brand Equity To Remain the Key in A Restricted Environment

Market Indicators

Table 11 Consumer Expenditure on Health Goods and Medical Services 2006-2011

Table 12 Life Expectancy at Birth 2006-2011

Market Data

Table 13 Sales of Consumer Health by Category: Value 2006-2011

Table 14 Sales of Consumer Health by Category: % Value Growth 2006-2011

Table 15 Consumer Health Company Shares 2007-2011

Table 16 Consumer Health Brand Shares 2008-2011

Table 17 Penetration of Private Label by Category 2006-2011

Table 18 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011

Table 19 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011

Table 20 Forecast Sales of Consumer Health by Category: Value 2011-2016

Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements - Registration and Classification

Switch Climate

Self-medication and Preventative Medicine

Generics

Switches

Summary 7 OTC - Switches 2009-2011

Sources

Summary 8 Research Sources

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: